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Summary   24 
Pandoraea species have emerged as opportunistic pathogens among cystic fibrosis (CF) 25 
and non-CF patients.  P. pulmonicola is the predominant Pandoraea species among Irish 26 
CF patients.  The objective of this study was to investigate the pathogenicity and potential 27 
mechanisms of virulence of Irish P. pulmonicola isolates and strains from other 28 
Pandoraea species.  Three patients from whom the P. pulmonicola isolates were isolated 29 
have died.  In vivo virulence of these and other Pandoraea strains was examined by 30 
determining killing of Galleria mellonella larvae.  P. pulmonicola strains generally were 31 
the most virulent tested, with three showing a comparable or greater level of virulence in 32 
vivo relative to another CF pathogen, Burkholderia cenocepacia, while strains from two 33 
other species, P. apista and P. pnomenusa, were considerably less virulent.  For all 34 
Pandoraea species, whole cells were required for larval killing, as cell free supernatants 35 
had little effect on larval survival.  Overall, invasive Pandoraea strains showed 36 
comparable invasion of two independent lung epithelial cell lines, irrespective of whether 37 
they had a CF phenotype.  Pandoraea strains were also capable of translocation across 38 
polarised lung epithelial cell monolayers.  Although protease secretion was a common 39 
characteristic across the genus, it is unlikely to be involved in pathogenesis.  In 40 
conclusion, while multiple mechanisms of pathogenicity may exist across the Pandoraea 41 
genus, it appears that lung cell invasion and translocation contributes to the virulence of 42 
P. pulmonicola strains.   43 
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Introduction  44 
Pandoraea species are characterized as non-spore forming, catalase, positive aerobic 45 
Gram negative rods with polar flagella, that are often mistakenly identified as 46 
Burkholderia cepacia complex (Bcc) or  Ralstonia spp. (Schneider et al., 2006; 47 
Stryjewski et al., 2003).  The genus Pandoraea contains five named species: P. apista, P. 48 
pulmonicola, P. pnomenusa, P. sputorum, P. norimbergensis (Stryjewski et al., 2003; 49 
Vandamme et al., 2000) and have been isolated from patients with respiratory tract 50 
infections as well as from soil, water and food (Schneider et al., 2006).  Its closest 51 
phylogenetic relative is the genus Burkholderia, and like members of the genus 52 
Burkholderia, it has recently emerged as a pathogen in the cystic fibrosis (CF) 53 
population.  CF is a genetically inherited disorder caused by mutations in the cystic 54 
fibrosis transmembrane regulator (CFTR), a chloride channel.  The main source of 55 
morbidity and mortality for CF patients, however, is the bacterial pathogens that they 56 
encounter throughout their lives, including, Pseudomonas aeruginosa and to a lesser 57 
extent, Bcc.   Although Pandoraea species have also been isolated from sputum samples 58 
of CF patients, there is still very little known about their mechanisms of pathogenicity or 59 
their roles in CF lung disease (LiPuma, 2003).  In addition, Pandoraea has been isolated 60 
from both CF and non-CF patients from a variety of clinical samples including, blood, 61 
sputum, urine, the upper airways and lung tissue (Pimentel & MacLeod, 2008).  The 62 
recovery of Pandoraea isolates from the blood of patients indicates that this organism is 63 
capable of invading tissue (Atkinson et al., 2006; Stryjewski et al., 2003).  Antibiotic 64 
therapy for infection is difficult due to the limited number of antibiotics to which these 65 
species are susceptible: tetracycline, imipenem and trimethoprim-sulfamethoxazole 66 
  4 
(Schneider et al., 2006). 67 
A systematic review of 102 publications recommended that CF patients colonised 68 
with either Pandoraea or Bcc species should be segregated from other non-colonised 69 
patients (Vonberg & Gastmeier, 2005).  However, the clinical significance of 70 
colonization with these organisms remains unclear (Atkinson et al., 2006) and there are 71 
limited and conflicting data available on the clinical outcome of patients colonised with 72 
Pandoraea.   Two CF patients chronically colonised with P. apista were culture negative 73 
post-bilateral transplants after antibiotic therapy (Atkinson et al., 2006).  However, 74 
apparent patient- to- patient transmission of P. apista has been demonstrated, and four of 75 
the patients exhibited a decrease in lung function post-acquisition (Jorgensen et al., 76 
2003).  P. pnomenusa  sepsis and subsequent death has been reported in a non-CF patient  77 
after a lung transplant (Stryjewski et al., 2003).   A recent case report highlighted nine 78 
previous reports of  Pandoraea bacteraemia, only one of these was identified as being in 79 
a CF patient (Pimentel & MacLeod, 2008). 80 
The predominant Pandoraea species among Irish CF patients is P. pulmonicola.  81 
We have previously shown that the Irish P. pulmonicola isolates were unusual within the 82 
genus as they all showed an ability to invade human lung epithelial A549 cells in vitro 83 
(Caraher et al., 2008).  The three patients from whom the P. pulmonicola isolates were 84 
obtained have since died.  Therefore the virulence of these P. pulmonicola isolates 85 
required further study.  We compared a selection of these isolates with other strains an in 86 
vivo virulence model, Galleria mellonella and also examined the interactions between 87 
some of these P. pulmonicola isolates and lung epithelial cells in more detail.   The G. 88 
mellonella model was chosen as it has previously been used to examine virulence of a 89 
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number of CF pathogens including Bcc, P. aeruginosa and Aspergillus fumigatus 90 
(Kavanagh & Reeves, 2004; Reeves et al., 2004; Seed & Dennis, 2008).  The non-Irish 91 
strains were all sourced from a commercial bacterial culture collection and were all 92 
originally isolates from CF lung (Table 1).    93 
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Materials and Methods   94 
 95 
Bacterial Strains and Cell lines.   The origins of the Pandoraea strains examined in this 96 
study are listed in Table 1. The non-Irish isolates were purchased from BCCM/LMG, 97 
University of Ghent, Belgium.  Non-invasive E. coli strain NCIB 9485 was used as a 98 
control in all experiments. All isolates were routinely grown on Tryptic soy agar (TSA), 99 
Tryptic soy broth (TSB), Luria–Bertani (LB) agar or LB broth at 37 oC.   All cell lines 100 
were maintained in a humidified atmosphere at 37oC in 5% CO2.  Calu-3 cells (sub-101 
bronchial epithelial cells) were obtained from the European Collection of Cell Cultures 102 
(ECACC) and maintained as previously described. (Shen et al., 1994).  16HBE14o- 103 
(human bronchial epithelial cells with functional CFTR) and CFBE41o- (CF bronchial 104 
epithelial cells) were kindly donated by Dr. Dieter Gruenert (University of California, 105 
San Francisco, UCSF) and maintained in fibronectin-vitrogen coated flasks containing 106 
MEM supplemented with 5 mM L-glutamine, 50 U ml-1 penicillin, 50 µg ml-1 107 
streptomycin and 10% (v/v) FBS.  108 
 109 
Determination of virulence in vivo using Galleria mellonella larvae.  Sixth instar 110 
larvae of G. mellonella were obtained from Live Foods Direct (Sheffield, England) and 111 
stored in wood shavings in the dark at 15 °C. Ninety larvae (0.2 to 0.4g) were randomly 112 
chosen for each strain assayed, and all experiments were performed on three independent 113 
occasions.  Bacterial cells were harvested by centrifugation at 4000 g for 10 minutes, 114 
washed in PBS, the O.D 600 was obtained and cultures diluted to a standard of 0.1 OD600.  115 
Bacterial cultures were then serially diluted to 10-7. Bioburden was ascertained, post 116 
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injection, by plate counts of dilutions 10-4 to 10-7, plated in triplicate. Ten larvae were 117 
inoculated with 20 l of each dilution, through the last pro-leg into the haemocoel using a 118 
0.3 ml Myjector syringe (Terumo Europe, Leuven, Belgium) and incubated in Petri 119 
dishes, on filter paper, at 37 °C for 72 h in the dark. The control group consisted of 10 120 
larvae injected with 20 l sterile PBS.  No more than one control larva died in any given 121 
trial.  In instances where more than one larva died in the control group, the data from the 122 
entire experiment was discarded.   Larval death was followed for 72h, at 24 h intervals, 123 
by visual inspection and by the lack of movement when stimulated. Three independent 124 
trials were conducted consisting of 10 larvae per bacterial concentration for each 125 
specified strain.   Results are presented as LD50 values, i.e. the inoculum concentrations 126 
which resulted in 50% killing of the larvae in 72 h.  Survival over time was also 127 
monitored and plotted against the serially diluted bacteria (1 to 1 x 106 CFU) and 128 
representative graphs of three experiments are shown.    To assess the virulence of cell-129 
free supernatant (CFS), bacterial cultures were pelleted by centrifugation at 4000rpm for 130 
10 mins. Supernatants were then passed through 0.22 µm pore filters to remove all 131 
bacteria. An aliquot of 20 µl were injected into 10 larvae. Sterile broth was used as 132 
control.   133 
 134 
 Invasion assay.  The ability of Pandoraea strains to invade epithelial cells was 135 
investigated as outlined  previously (Caraher et al., 2008). Lung epithelial cells 136 
(16HBE14o- or CFBE41o-) were seeded on 24 well plates (4×105 cells per well) in media 137 
containing 10% FBS, without antibiotics and cultured for 24 h at 37oC in 5% CO2.  All 138 
bacterial strains were grown to an optical density at 600 nm (O.D.600) of 0.6 and 139 
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resuspended at the appropriate dilution, as determined by growth curves, in tissue culture 140 
media without antibiotics.  These bacterial suspensions were then added to the epithelial 141 
cells at multiplicity of infection of 50:1, as used previously.  Intracellular invasion was 142 
determined over 2 h following antibiotic killing of extracellular bacteria with 1mg 143 
amikacin ml-1.  The percentage invasion was determined as follows:  c.f.u. recovered 144 
from lysed cells / c.f.u. applied to the cells) X 100.   145 
 146 
Measurement of trans-epithelial electrical resistance (TER).  Calu-3 cells were seeded 147 
onto Transwell® polycarbonate inserts (0.4 µm) and after one day, the cells were 148 
maintained at an air-liquid interface, in order to promote differentiation (Foster et al., 149 
2000).  The trans-epithelial electrical resistance (TER) was monitored for 14 days using 150 
an EVOM voltohmmeter (World Precision Instruments) to ensure polarisation and 151 
formation of tight junctions and the cells were fed basolaterally on alternate days.   Prior 152 
to infection of the epithelial cells, each strain was grown to an O.D of 0.6 at 600 nm and 153 
0.5 ml of the appropriate dilution of bacterial suspension was added to the apical 154 
compartment and incubated at 37oC. E. coli strain, NCIB 9485, was used as a negative 155 
control. TER was measured at 0, 1, 2 and 4 h post-infection. 156 
 157 
Translocation studies.  In order to examine the translocation of bacteria through the 158 
epithelial monolayer,  Calu-3 cells were seeded at a density of 7.5×105 cells per insert on 159 
3.0 µM Transwell® polycarbonate inserts, a pore size which enables passage of the 160 
bacteria to the basolateral chamber (Duff et al., 2006).  The cells were cultured fed 161 
basolaterally on alternate days for a period of up to 21 days.   After apical application of 162 
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bacteria (MOI = 50:1), TER was monitored up to 3 h and the basolateral media was 163 
sampled periodically and serial diluted in Ringer’s solution to determine the cfu ml-1 that 164 
translocated through the cell monolayer (Duff et al., 2006). 165 
 166 
 167 
Protease activity assay.  For detection of general protease secretion, 100 µL of cell free 168 
supernatants (CFS) from an overnight culture of each of the Pandoraea strains,  were 169 
placed into wells on skimmed milk agar plates (3 and 10% w/v) containing nutrient agar.  170 
This method provides a convenient and clear determination of protease detection on 171 
visual inspection and is suitable for evaluating a multiple bacterial strains simultaneously.  172 
Sterile broth was used as a negative control and E. coli strain, NCIB9485, and 173 
Burkholderia cenocepacia strain, BC7, were used as positive controls.  The plates were 174 
incubated at 37oC for 24- to- 48 h and any zones of inhibition were measured (mm) using 175 
digital Vernier callipers (Lennox, Ireland).    176 
 177 
Statistical analysis.  Dunn’s multiple comparison method was used to compare 178 
invasiveness of individual strains compared to the negative control. A p-value of <0.05 179 
was deemed to be significant in each case.  Students’ t-test was used to compare the TER 180 
values of bacteria treated monolayers relative to control at individual time points, 181 
apparent permeability coefficients and also to compare % survival of G. mellonella at 182 
specific time points  following exposure to cell free supernatants.  In vivo virulence data 183 
for individual strains was compared with one-way ANOVA (Minitab).  184 
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Results 185 
 186 
Patients and isolates.     Patient 1 was an adult female patient that was colonised with P. 187 
pulmonicola at 36 years (RL7177).  She was chronically colonised and a second isolate 188 
(RL8228) was obtained nine months after the first isolate.  Her forced expiratory volume 189 
(FEV1) fell from 54% at the time of first isolation of P. pulmonicola to 41% at the time of 190 
the second isolation and continued to decline down to 21% at 44 months after the first P. 191 
pulmonicola isolation.   Her hospital admissions increased from an average of 0.6 per 192 
year prior to Pandoraea acquisition to 3 per year in the subsequent 3 years.  She died 52 193 
months after her first Pandoraea isolation, having spent the last 21 months as an in-194 
patient. 195 
 196 
Patient 2 was an adult female that was colonised with P. pulmonicola (RL0345) at 23 197 
years.  She was chronically colonised and a second Pandoraea isolate was obtained 8 198 
months after the first isolation and identification.  Her FEV1 fell from 35% to 33% in the 199 
year prior to first isolation of P. pulmonicola, and dropped from 33% to 26% in the 12 200 
months post-P. pulmonicola isolation.  Although her hospital admissions did not change 201 
substantially post-acquisition of P. pulmonicola (2.5 admissions per year in the preceding 202 
years compared to four in the subsequent 12 months), she died 14 months after first 203 
isolation of Pandoraea.   204 
 205 
Patient 3 was also an adult female patient colonised with P. pulmonicola (RL0308) at 19 206 
years.  Her hospital admissions increased from an average of two per year in the three 207 
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years prior to Pandoraea isolation to 4 per year following Pandoraea isolation.  She had 208 
a lung transplant 5 months after first isolation of Pandoraea.  Her FEV1 was 64% at 7 209 
months post-transplant and decreased to 39%, 11 months post-transplant.  She 210 
subsequently died 2 years and 1 month after transplantation, Pandoraea was not 211 
identified in the patient post-transplant.     212 
 213 
P. pulmonicola strains are more virulent in vivo than other Pandoraea species.  We 214 
first examined the survival of G. mellonella larvae in response to the four Irish clinical P. 215 
pulmonicola isolates and to five other strains within the genus Pandoraea and compared 216 
them with values obtained for the B. cenocepacia strain, J2315.  This Bcc strain was 217 
chosen as it has been previously tested in the G. mellonella model (Seed & Dennis, 218 
2008).  Although variability was observed across the genus, there were clear species-219 
specific effects on G. mellonella survival.  The four most virulent Pandoraea strains, 220 
with the lowest LD50 at 72 h, were all P. pulmonicola strains (Table 1).  Four out of six P. 221 
pulmonicola strains examined (RL7177, RL8228, LMG 18107 and LMG 18108) were 222 
quite virulent and showed comparable or greater virulence relative to that of B. 223 
cenocepacia strain, J2315 (Table 1, p = 0.147).   The fact that the four most virulent 224 
strains included two patient isolates and two from a commercial source indicates that this 225 
effect is not biased towards Irish clinical isolates or commercially-sourced isolates.   Both 226 
P. apista strains examined (LMG16407 and LMG 16408) exhibited high LD50 values, 227 
indicating that they were less virulent.  The only P. pnomenusa strain examined also had 228 
a high LD50 value.    Interestingly, the two sequential P. pulmonicola isolates (RL7177 229 
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and RL8228) obtained from Patient 1 showed a dramatic reduction in LD50 over time 230 
between isolates indicating that virulence had increased with time.    231 
 The kinetics of killing varied across the genus.  Individual P. pulmonicola strains 232 
became more lethal with time following the injection (fig 1a to 1c), while P. apista and P 233 
pnomenusa strains, all had their optimal effect within 24 h with no significant 234 
enhancement after that time (for example, P. apista LMG 16408, Fig. 1d).  All other P. 235 
pulmonicola strains also showed this time-dependent effect (data not shown).    236 
 237 
 238 
Cellular invasion Pandoraea spp is independent of cystic fibrosis phenotype. We 239 
have previously shown that only a subset of Pandoraea strains was capable of invading 240 
lung epithelial cells.  Indeed, the Irish P. pulmonicola strains were unusual in that the 241 
majority of these were capable of invading A549 cells (Caraher et al., 2008).  To 242 
investigate the invasive potential of the P. pulmonicola isolates further, we examined the 243 
potential of a selection of these strains to invade lung epithelial cells with, and without, a 244 
CF phenotype in order to examine whether cells with a CF phenotype (CFBE41o- cells) 245 
were more susceptible to invasion by members of the genus, relative to lung epithelial 246 
cells with functional CFTR (16HBE14o- cells).   An MOI of 50:1 was used as previous 247 
studies had shown that invasion was optimal at this MOI.    Three clinical P. pulmonicola 248 
isolates which were previously found to invade A549 cells (Caraher et al., 2008) were 249 
selected, including two sequential isolates (RL7177 and RL8228) from one patient,  to 250 
examine their potential to invade these two distinct cell lines (16HBE14o- and CFBE41o-251 
).  These were compared with another strain previously shown to be moderately invasive, 252 
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P. pnomenusa strain, LMG18087.  Three Pandoraea strains (P. pulmonicola RL0345 and 253 
RL8228, and P. pnomenusa LMG18087) were invasive in the 16HBE14o- cells, when 254 
compared to the negative control E. coli strain, NCIB9485,  (p <0.05 by Dunn’s multiple 255 
comparison method in each case) (Fig 2).  The remaining isolate, P. pulmonicola 256 
RL7177, was classified as non-invasive because the invasion values were not 257 
significantly different from that of the control E. coli strain, NCIB9485.   Only two of the 258 
Pandoraea isolates, P. pulmonicola RL0345 and RL8228,  invaded CFBE41o- cells (Fig 259 
2) when compared to the negative control E. coli, NCIB9485 (P<0.05).  The other two 260 
isolates, P. pnomenusa LMG18087 and P. pulmonicola RL7177, were not significantly 261 
more invasive of CFBE cells than E. coli strain, NCIB 9485.   There was no statistically 262 
significant difference in invasion of any strain into CFBE41o- cells versus 16HBE14o- 263 
cells. Although these cell lines are distinct, this study suggests that cells with a CF 264 
phenotype are no more susceptible to invasion by Pandoraea strains than those with 265 
functional CFTR.   Interestingly, a consistent increase in invasive potential in the two 266 
sequential isolates, RL7177 and RL8228, in both lung epithelial cell lines suggests that 267 
these strains become more invasive with time.   268 
 269 
P. pulmonicola strains can translocate through polarised lung epithelia.   Pandoraea 270 
has been isolated from the blood of patients (Atkinson et al., 2006; Daneshvar et al., 271 
2001; Stryjewski et al., 2003) but the majority of strains previously examined were not 272 
invasive (Caraher et al., 2008).  Therefore, we wanted to examine whether Pandoraea 273 
strains were able to invade through the lung epithelium from the apical side to the 274 
basolateral side, Calu-3 cells were grown as polarised monolayers on  filters with pore 275 
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size sufficiently large (3 µm) to enable bacteria to pass through the filter to the 276 
basolateral chamber.  Although development of a tight epithelium was slower than that 277 
observed for  Calu-3 cells when cultured on the smaller pore-size (0.4 µm) filters (Duff et 278 
al., 2006), the TER peaked at 150 Ω /cm2 over that of blank filters on day 21.  All 279 
experiments were carried out on monolayers that had a TER of no less than 150 Ω /cm2 280 
above that of the control well.  Bacterial counts from the basolateral chamber indicated 281 
that all four strains examined appeared to translocate within 3 h (Fig. 3a).  The P. apista 282 
strain, LMG16408, (previously shown to be non-invasive) (Caraher et al., 2008),  was the 283 
slowest to translocate, reaching levels in the basolateral chamber of 1% (2 x 105) of 284 
bacteria applied over the 3 h. During this time, all the other strains appeared to 285 
translocate, in excess of 1x106 cfu ml-1.  The strain which translocated most readily was 286 
P. pnomenusa strain, LMG 18087.    287 
                           288 
To evaluate if the observed translocation of Pandoraea strains was mediated by 289 
disruption of tight junctions, Calu-3 cells were grown on 0.4 uM Transwell® filters for 14 290 
days, by which time the TER were routinely greater than 1000 Ω /cm2.  The sequential P. 291 
pulmonicola isolates, RL7177 and RL8228, both resulted a significant drop in TER over 292 
time when applied to Calu-3 monolayers,  relative to E. coli strain, NCIB 9485, p<0.015 293 
for both strains (Fig 3b). Three other strains which were shown to translocate were 294 
examined namely, P. pulmonicola RL0345, P. pnomenusa LMG18087 and P. apista 295 
LMG16408 did not cause a statistically significant reduction in TER.  We have 296 
previously shown that the virulent CF pathogen B. cenocepacia strain, BC7 disrupted 297 
tight junction integrity in polarised Calu-3 cells (Duff et al., 2006); therefore this was 298 
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included as a positive control.   The drop in TER following infection with the B. 299 
cenocepacia strain, BC7, was found to be comparable with that of both P. pulmonicola 300 
isolates, RL7177 and RL8228.  The TER at 4 h fell to 64% + 14 following infection with 301 
BC7 (excluded from Fig 3b for clarity), compared to 59 % for RL7177 and 66 % for 302 
RL8228. 303 
    304 
Pandoraea isolates secrete proteases but these are not involved in larval killing.  305 
Protease secretion by Pandoraea strains could play a role in disruption of tight junctions 306 
or general lung tissue damage; therefore we wanted to determine the levels of protease 307 
secretion in a selection of the clinical Irish isolates and other strains.   The protease 308 
activities of a range of Pandoraea isolates were examined on 3% or 10%  skimmed milk 309 
agar plates together with E. coli NCIB9485 and B. cenocepacia strain BC7 which were 310 
used as a positive controls in these studies (Gingues et al., 2005; Swamy & Goldberg, 311 
1982).  All Irish P. pulmonicola isolates examined produced significant levels of protease 312 
activity.  This level was comparable to all other Pandoraea strains examined and was 313 
also comparable to  the levels of protease activity of both the E. coli strain, NCIB9485 314 
and the B. cenocepacia strain, BC7  (Fig. 4).   315 
 316 
The role of proteases in pathogenesis was examined by injecting CFS from a series of 317 
Pandoraea isolates into the G. mellonella model.  In contrast to the killing of larvae by 318 
whole cells, when CFS were administered to the larvae, no killing was observed by 319 
Pandoraea strains examined up to 1 week post-injection.  This clearly indicates that in 320 
general cellular components rather than secreted factors play a role in killing among the 321 
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Pandoraea genus.  This contrasts with the effects of CFS from B. cenocepacia strain 322 
J2315 (Fig 5A) which resulted in significant killing of G. mellonella larvae within 72 h 323 
(70%).   Interestingly, in spite of the lack of effect on survival, the CFS of certain strains, 324 
e.g. P. pulmonicola strains, LMG18107 and LMG18108, and P. pnomenusa strain, LMG 325 
18087, had a reversible pathogenic effect on the larvae.  The larvae underwent 326 
melanisation within 30 minutes (Fig 5C) and subsequently recovered without any effect 327 
on survival.  This melanisation was never observed in the control larvae injected with LB 328 
broth only (Fig 5B), however, melanisation always preceded death of larvae that were 329 
injected with whole cells (Fig 5D).     330 
 331 
 332 
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Discussion 333 
Pandoraea species are a relatively recently identified pathogen among CF and non-CF 334 
patients (LiPuma, 2003; Pimentel & MacLeod, 2008; Stryjewski et al., 2003).  Although 335 
Pandoraea has been isolated from the blood and sputum samples of patients, very little is 336 
known about its virulence or mechanisms of pathogenicity.  P. pulmonicola are the most 337 
commonly identified Pandoraea species among Irish CF patients.  However, there is very 338 
little known about this species in particular, in terms of the outcomes of infected patients 339 
or its pathogenicity, therefore we have focussed, although not exclusively, on this 340 
species.  All three patients from whom P. pulmonicola was isolated were female.  This is 341 
an unavoidable bias in this study, however, there were not enough patients to allow a 342 
more gender-balanced approach.   In our experience, no gender bias has been observed in 343 
Pandoraea colonisation.   344 
 Firstly, in order to compare the potential virulence of Pandoraea species and 345 
strains, we evaluated nine strains in an in vivo virulence model.  The larvae of G. 346 
mellonella has recently been used to evaluate a series of Bcc strains for their virulence 347 
and their responses to phage therapies (Seed & Dennis, 2008, , 2009).  They have also 348 
been used to study the virulence of other bacterial and fungal pathogens  (Jander et al., 349 
2000; Reeves et al., 2004).  The host response of G. mellonella to infection shares many 350 
similarities with that of vertebrates (Kavanagh & Reeves, 2004), making it a cheaper 351 
alternative to other in vivo models.  It has advantages over other in vivo models, such as 352 
Caenorhabditis elegans, as Galleria larvae can survive at 37oC.    The pattern of survival 353 
of G. mellonella following infection with Pandoraea strains was species-specific.    354 
Although, the in vivo studies are limited in that they were performed in a single model, it 355 
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is clear that the P. pulmonicola strains were among the most virulent of the three species 356 
tested in this model, while other species, P. apista and P. pnomenusa were only weakly 357 
virulent (Table 1).    358 
 P.  pulmonicola was also the species in which the majority of strains displayed a 359 
potential for epithelial cell uptake (Caraher et al., 2008), therefore, in order to further 360 
investigate invasion as a mechanism of virulence within these Pandoraea strains, we 361 
compared invasion in cells with, and without, a CF phenotype. Although the magnitude 362 
of invasion into CFBE cells was less in general, the pattern of invasion (i.e. invasive or 363 
not) of Pandoraea isolates into both independent cell lines was comparable with invasion 364 
of A549 cells.  In particular, two Irish P. pulmonicola isolates, RL0345 and RL8228, 365 
which showed considerable invasive capacity of A549 cells, were also found to be 366 
significantly invasive in both 16HBE14o- and CFBE41o- epithelial cell models. This 367 
demonstrates the ability of certain Pandoraea isolates to invade three independent lung 368 
epithelial cells and indicates that invasion is strain-specific rather than cell phenotype-369 
dependent. The lack of enhanced susceptibility to invasion of cells with a CF phenotype 370 
over non-CF cells would agree with a recent summary of nine Pandoraea bacteraemia 371 
cases reported (Pimentel & MacLeod, 2008), at least three of which were identified as 372 
being in non-CF patients.   The finding that P. pulmonicola isolate, RL8228, was both 373 
more invasive of human lung cells and more virulent to larvae than the earlier isolate 374 
(RL7177) from the same patient, suggests that invasion plays a role in pathogenesis for 375 
some members of the species.   However, the finding that two other P. pulmonicola 376 
strains (LMG18107 and LMG18108) which were very virulent towards the larvae, but 377 
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were not previously shown to be invasive, indicates that other mechanisms of 378 
pathogenicity are also at play.   379 
 In order to explore mechanisms of lung invasion further, the ability of a selection 380 
of isolates to disrupt epithelial integrity prior to entering the blood stream was examined.  381 
Human lung epithelial cells, such as Calu-3,  show permeability properties which are 382 
comparable to native lung epithelia and therefore are a useful model for studying the 383 
absorption barrier of the lung (Forbes & Ehrhardt, 2005).   We and others have shown 384 
that Bcc strains can disrupt the tight junction integrity of, and penetrate through, lung 385 
epithelial monolayers (Duff et al., 2006; Kim et al., 2005).  Although all four Pandoraea 386 
isolates tested had the ability to translocate through the monolayer, albeit at different 387 
rates, two of the strains examined translocated without having any effect on TER (Fig. 3).  388 
This suggests that these pathogens move through the monolayer via an alternative route 389 
to the paracellular pathway.   390 
Despite the diversity across the genus, all Pandoraea strains tested secreted 391 
significant levels of protease and the three Pandoraea species examined showed 392 
comparable protease activities.   Bacterial proteases have been implicated in a number of 393 
pathogenic processes, including disruption of epithelial integrity, inflammation and tissue 394 
damage.  However, the lack of effect of CFS in the in vivo model suggests that the 395 
secreted proteases, in general, may not play any major role in pathogenesis.   396 
Furthermore, the lack of correlation between protease activity and tight junction 397 
disruption suggests that proteases are not likely to be responsible for this effect.  In 398 
contrast, members of the closely related Bcc and also Ps. aeruginosa express 399 
metalloproteases which have been shown to be involved in virulence (Kooi et al., 2006; 400 
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McKevitt & Woods, 1984).   In addition, serine proteases have also been identified in B. 401 
cenocepacia, and although one of these has been shown to play a role in iron acquisition, 402 
their roles in pathogenicity have not been confirmed (Flannagan et al., 2007; Whitby et 403 
al., 2006).  The relatively high levels of general protease secretion across the genus are 404 
interesting, and the identity of these proteases is currently being investigated.  It remains 405 
a possibility that specific proteases may play a role in virulence of Pandoraea species. 406 
Overall, the lack of effect of CFS on G. mellonella survival for any species within the 407 
genus, indicates that the whole cells are the main mediator of virulence rather than 408 
secreted exoproducts strengthening the suggestion for direct interaction between the 409 
bacterial cells and the host cells as part of the virulence process.  410 
 This study shows that the genus Pandoraea is quite divergent in terms of their 411 
virulence characteristics, indeed, it was named for the potential Pandora’s box of genetic 412 
diversity associated with these organisms (Vandamme et al., 2000).  In general, P. 413 
pulmonicola strains are the most invasive and also the majority of strains from this 414 
species showed the most virulence in the in vivo model, however, to the best of our 415 
knowledge, there have been no reported cases of P. pulmonicola related bacteraemia.  416 
Given the small numbers involved, it is difficult to correlate in vitro behaviour with 417 
clinical outcomes in patients; however, it is significant that all P. pulmonicola colonised 418 
patients from which the isolates in this study were obtained, have died.  Further studies 419 
would be required on much greater numbers to draw any definite conclusions.   420 
 P. apista strains examined showed the lowest virulence in G. mellonella, were 421 
non-invasive and P. apista strain LMG16408 was the slowest to translocate across the 422 
polarised lung epithelium, however, this species has been associated with at least two 423 
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cases of septicaemia (Daneshvar et al., 2001; Johnson et al., 2004). Only one P. 424 
pnomenusa strain, LMG18087, was included in this study and although invasive of lung 425 
cells expressing CFTR, was not invasive in cells with a CF phenotype.  This strain 426 
showed the greatest level of trans-epithelial translocation among the four examined.   427 
Interestingly, four cases of P. pnomenusa associated bacteraemia have been reported 428 
(Daneshvar et al., 2001; Stryjewski et al., 2003).  Indeed, all three isolates identified as P. 429 
pnomenusa by Daneshvar et al., were isolated from blood which led the authors to 430 
suggest that this species might have increased potential for invasive disease (Daneshvar 431 
et al., 2001).  The mechanism of P. pnomenusa translocation is not linked to tight 432 
junction opening; therefore further analysis of this species is warranted.   433 
 The changes in sequential P. pulmonicola isolates, RL7177 and RL8228, are 434 
noteworthy.  The later isolate is more invasive of lung epithelial cells and more virulent 435 
to larvae.   Furthermore, in our previous study, we demonstrated that the early isolate, 436 
RL7177 was the only Pandoraea strain out of 19 examined which was capable of biofilm 437 
formation (Caraher et al., 2008), suggesting that this strain also undergoes a mucoid to 438 
non-mucoid change over time.  This change from a mucoid to a non-mucoid state has 439 
also been observed in Bcc isolates from chronically infected patients (Zlosnik et al., 440 
2008), indicating that the same phenotype change arises among P. pulmonicola isolates, 441 
however, more sequential isolates would need to be studied to confirm this.  In addition, 442 
further study in the existing sequential isolates is being performed to elucidate the 443 
apparent alteration in virulence over time.   444 
 Overall, it is clear that P. pulmonicola strains show comparable in vivo virulence 445 
to B. cenocepacia strain J2315 in a G. mellonella model.  A subset of P. pulmonicola 446 
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strains were shown to invade lung epithelial cells irrespective of CF status and four 447 
strains examined showed the potential to translocate across the lung epithelium.  In 448 
addition, although protease secretion is a common feature among all strains examined, 449 
there is no clear evidence to date that this may be a virulence mechanism in this genus.   450 
It is likely that individual species within the Pandoraea genus have the potential to 451 
express very different mechanisms of pathogenesis, as demonstrated by differences in 452 
intracellular invasion, tight junction disruption and larval killing.    This is comparable to 453 
the situation in Bcc strains which appear to use different virulence mechanisms to 454 
compete for survival in different environments and hosts (Uehlinger et al., 2009).   There 455 
are limited clinical data published on Pandoraea infections, and the numbers of isolates 456 
evaluated in this study are also limited, therefore it is difficult to draw clear conclusions 457 
regarding the mechanisms of pathogenicity and the effects on patients.   In addition, 458 
major host-related factors are also at play and furthermore, given that many Pandoraea 459 
colonised patients are also co-colonised with other pathogens, the interplay between 460 
competing species must also be considered.    However, it is clear that P. pulmonicola 461 
does contribute to the deterioration of colonised patients and has a direct interaction with 462 
lung epithelial cells.    463 
   464 
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Legends:  
Fig.1. Kinetics of larval killing by Pandoraea strains.  Survival of G. mellonella at 24 h 568 
(•), 48 h (o) or 72 h  () when infected with either P. pulmonicola strains, RL8228 (A),  569 
RL0345 (B), LMG18108 (C) or P. apista strain, LMG 16408 (D).  Each data set is from a 570 
single trial (n=10) which was representative of three independent trials with the specified 571 
strain.   The data are presented as % larval survival from 10 larva injected per trial.  No 572 
more than one control larva died in any given trial.   573 
 574 
Fig. 2.  Comparison of invasion by Pandoraea strains in two lung epithelial cells, 575 
16HBE14o- cells and CFBE41o-, compared to the negative control E. coli strain, 576 
NCIB9485. Bars represent % invasion (c.f.u. obtained after cell lysis as a percentage of 577 
c.f.u. applied) of at least five independent experiments for 16HBE14o- cells and at least 578 
three independent experiments for CFBE41o-. Error bars represent ± SEM; * denotes 579 
invasion significantly greater than E. coli, as determined by Dunn’s multiple comparison 580 
test (p<0.05). 581 
 582 
Fig. 3.  The translocation of Pandoraea strains through polarised Calu-3 epithelial 583 
monolayers.   A) Cumulative bacterial counts taken from basolateral chamber of Calu-3 584 
cell monolayers grown on 3 µm Transwell® filters at 1, 2 and 3 h post infection with 585 
Pandoraea strains expressed total CFU translocated /ml.  The results are the average data 586 
from at least two independent experiments ± SEM.  B) The effect of Pandoraea strains 587 
on TER at 0, 1, 2 and 4 h post-infection, presented as % of the control (1092 + 225) and 588 
representing the mean of at least three independent experiments, error bars represent  ± 589 
SEM.  590 
  28 
 591 
Fig. 4.  Protease secretion from Pandoraea species as determined on skimmed milk agar 592 
plates.  Bars represent zones of clearance (+ standard deviation) measured following 48 h 593 
incubation of Pandoraea cell free supernatants on 3%  (black bars) or 10% (grey bars) 594 
(v/v) skimmed milk plates from three independent experiments.   595 
 596 
Fig. 5. The effects of cell free supernatant on survival of G. mellonella.  A) The bars 597 
represent % survival of 10 larvae at 24 h, 48 h, 72 h, respectively.  Each data point 598 
represents the mean of three independent experiments + SEM; * p<0.05, relative to LB 599 
injected control group.  B-D) Effect of P. pulmonicola RL7177 CFS on G. mellonella, B) 600 
control larvae 30 min  post-injection with TSB only; C) Larvae 30 min post-injection 601 
with CFS from LMG 18108; D); Larvae 48 h post-injection with whole cells, indicating 602 
killed larvae among melanised larvae.   603 
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 TABLE 1.  Summary of origins of Pandoraea strains and isolates used in this study and 
their relative LD50s values obtained in G. mellonella larvae 72 h post infection compared 
with B. cenocepacia strain, J2315.   
Species Strain Source  LD50 (72 h) +SEM 
P. 
pulmonicola 
RL7177  CF Lung (Ireland, Pt 1) 1 x 104 8.7+103 
 RL8228 CF Lung (Ireland, Pt 1) 171 159 
 RL0345 CF Lung (Ireland, Pt 2) 3.85 x 105 71.5 x 104 
 RL0308 CF Lung (Ireland, Pt 3) 5.12 x 105 3.8 x 105 
 LMG18107 CF lung (USA) 1.54 1.0 
 LMG18108 CF lung (USA) 31.3 30 
 
    
P. apista LMG16407 CF lung (Denmark) 8.8 x 106 2.0 x 105 
 LMG16408 CF lung (Denmark) 1.27 x 106 4.4 x 105 
 
    
P. 
pnomenusa 
LMG18087 CF lung (UK) 5.2 x 106 6.7 x 105 
  
   
B. 
cenocepacia 
J2315 CF lung (USA)  4100 3412 
 BC7 CF lung (USA) ND  
 604 
LD50 is defined as the CFU required to kill 50% of the G. mellonella larvae in 72 h.  605 
These data represent the mean of three independent trials with ten larvae per group.   606 
ND:   not determined.   607 
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Figure 2.  
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Figure 3.   
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Figure 5.   
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